Jeff Bechard

Jeff Bechard is a Senior Principal Scientist in Toxicology at Xenon Pharmaceuticals Inc., with extensive experience in nonclinical safety and drug development. Prior roles include Senior Principal Scientist at Arbutus Biopharma, Study Director at Alberta Innovates - Technology Futures, Group Leader at Cardiome Pharma Corp, and Scientist at Inflazyme Pharmaceuticals. Educational qualifications include a Master of Science in Agriculture and a Bachelor of Science in Microbiology and Immunology from The University of British Columbia, as well as a Project Management Certification from NAIT. Jeff's career spans over two decades in the pharmaceutical and biotechnology industries.